Mutations in the nonstructural protein 5A gene and virological response to interferon in Turkish patients chronically infected with hepatitis C virus type 1b

被引：0
|
作者：
Akkiz, H
Colakoglu, S
Ergun, Y
Sandikci, M
Serin, M
Oksuz, M
Isiksal, F
Kacak, F
Abayli, B
机构：
来源：
JOURNAL OF HEPATOLOGY | 2001年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [41] Hepatitis C Virus Nonstructural 5A Protein Interacts with Telomere Length Regulation Protein: Implications for Telomere Shortening in Patients Infected with HCV
    Lim, Yun-Sook
    Nguyen, Men T. N.
    Pham, Thuy X.
    Huynh, Trang T. X.
    Park, Eun-Mee
    Choi, Dong Hwa
    Kang, Sang Min
    Tark, Dongseob
    Hwang, Soon B.
    MOLECULES AND CELLS, 2022, 45 (03) : 148 - 157
  • [42] Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein
    Gale, MJ
    Korth, MJ
    Tang, NM
    Tan, SL
    Hopkins, DA
    Dever, TE
    Polyak, SJ
    Gretch, DR
    Katze, MG
    VIROLOGY, 1997, 230 (02) : 217 - 227
  • [43] Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders
    Chayama, Kazuaki
    Takahashi, Shoichi
    Toyota, Joji
    Karino, Yoshiyasu
    Ikeda, Kenji
    Ishikawa, Hiroki
    Watanabe, Hideaki
    McPhee, Fiona
    Hughes, Eric
    Kumada, Hiromitsu
    HEPATOLOGY, 2012, 55 (03) : 742 - 748
  • [44] Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses
    Sarrazin, C
    Herrmann, E
    Bruch, K
    Zeuzem, S
    JOURNAL OF VIROLOGY, 2002, 76 (21) : 11079 - 11090
  • [45] Nonstructural protein 5A does not contribute to the resistance of hepatitis C virus replication to interferon alpha in cell culture
    Siepen, MAD
    Lohmann, V
    Wiese, M
    Ross, S
    Roggendorf, M
    Viazov, S
    VIROLOGY, 2005, 336 (02) : 131 - 136
  • [46] Virological response and safety of 24-week telaprevir alone in Japanese patients infected with hepatitis C virus subtype 1b
    Toyota, J.
    Ozeki, I.
    Karino, Y.
    Asahina, Y.
    Izumi, N.
    Takahashi, S.
    Kawakami, Y.
    Chayama, K.
    Kamiya, N.
    Aoki, K.
    Yamada, I.
    Suzuki, Y.
    Suzuki, F.
    Kumada, H.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 (03) : 167 - 173
  • [47] The nonstructural 5A protein of hepatitis C virus inhibits cellular responses to interferon in cultured cell lines.
    Kurosaki, M
    Enomoto, N
    Sakamoto, N
    Maekawa, S
    Nagayama, K
    Miyasaka, Y
    Izumi, N
    Sato, C
    HEPATOLOGY, 1998, 28 (04) : 272A - 272A
  • [48] Evidence for sequence selection within the non-structural 5A gene of hepatitis C virus type 1b during unsuccessful treatment with interferon-α
    Gerotto, M
    Dal Pero, F
    Sullivan, DG
    Chemello, L
    Cavalletto, L
    Polyak, SJ
    Pontisso, P
    Gretch, DR
    Alberti, A
    JOURNAL OF VIRAL HEPATITIS, 1999, 6 (05) : 367 - 372
  • [49] Interferon responsiveness in patients infected with hepatitis C virus 1b differs depending on viral subtype
    Nakano, I
    Fukuda, Y
    Katano, Y
    Toyoda, H
    Hayashi, K
    Hayakawa, T
    Kumada, T
    Nakano, S
    GUT, 2001, 49 (02) : 263 - 267
  • [50] Therapeutic Response Guided Interferon Therapy Among Patients Chronically Infected with Hepatitis C Virus
    Raza, Abida
    Aziz, Hafsa
    Zaman, Naseeb
    Yousuf, Iqbal
    Din, Faateh
    Murtaza, Shahnaz
    Irfani, Javed
    Muhammad, Mukhtar
    ANTIVIRAL RESEARCH, 2010, 86 (01) : A43 - A43
12345